Skip to main content
Log in

Prevalence and Management of Medication Interactions with Nirmatrelvir-Ritonavir at a Large Urban Academic Medical Center: An Observational Study

  • Concise Research Report
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19. Accessed April 1, 2023.

  2. Marzolini C, Kuritzkes DR, Marra F, et al. Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions. Ann Intern Med. 2022;175(5):744-746. https://doi.org/10.7326/M22-0281.

    Article  PubMed  Google Scholar 

  3. Culas R, Nath S. Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions. JAMA Intern Med. 2023; https://doi.org/10.1001/jamainternmed.2022.6834.

    Article  PubMed  Google Scholar 

  4. Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/ritonavir-boosted-nirmatrelvir--paxlovid-/paxlovid-drug-drug-interactions/. Accessed 28 June 2023.

  5. Ross SB, Bortolussi-Courval É, Hanula R, Lee TC, Goodwin Wilson M, McDonald EG. Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications. JAMA Netw Open. 2022;5(7):e2220184. https://doi.org/10.1001/jamanetworkopen.2022.20184.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements:

Funders: Dr. Anderson was supported by grant K76AG074878 from the National Institute on Aging.

Funding

National Institute on Aging,K76AG074878,Timothy S. Anderson

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas Spetko MD.

Ethics declarations

Conflict of Interest:

Dr. Anderson reports receiving grants from the American Heart Association, American College of Cardiology, US Deprescribing Research Network, and Boston OAIC Pepper Center outside of the submitted work. Dr. Herzig reports receiving grants from the Agency for Healthcare Research and Quality outside of the submitted work. Dr. Wang reports no conflicts of interest. Dr. Spetko reports no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spetko, N., Wang, B.X., Herzig, S.J. et al. Prevalence and Management of Medication Interactions with Nirmatrelvir-Ritonavir at a Large Urban Academic Medical Center: An Observational Study. J GEN INTERN MED (2024). https://doi.org/10.1007/s11606-024-08750-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11606-024-08750-6

Navigation